$376B
$1.25 Million
0.04% of portfolio
1,713
Q1 2024
Added 328.25%
$172B
$1.05 Million
0.04% of portfolio
24,196
Q1 2024
Reduced 22.44%
$6.68B
$1.02 Million
0.04% of portfolio
18,631
Q3 2017
New
$12.6B
$1.16 Million
0.04% of portfolio
13,620
Q1 2024
Reduced 5.2%
$45.1B
$1.04 Million
0.04% of portfolio
6,049
Q1 2024
New
$12.2B
$1.07 Million
0.04% of portfolio
5,613
Q1 2024
New
$10.7B
$877,000
0.03% of portfolio
6,450
Q1 2023
Reduced 22.38%
$113B
$852,000
0.03% of portfolio
2,075
Q1 2024
Reduced 17.82%
$19.1B
$849,000
0.03% of portfolio
10,670
Q1 2024
Reduced 50.92%
$53.4B
$902,000
0.03% of portfolio
3,467
Q1 2024
New
$625B
$840,000
0.03% of portfolio
4,780
Q1 2024
Added 0.63%
$27B
$933,000
0.03% of portfolio
4,800
Q3 2017
New
$37.7B
$879,000
0.03% of portfolio
6,340
Q1 2024
Reduced 9.94%
$90.5B
$800,000
0.03% of portfolio
4,053
Q1 2024
New
$36B
$539,000
0.02% of portfolio
7,000
Q2 2019
Added 100.0%
$32B
$515,000
0.02% of portfolio
4,998
Q1 2024
Reduced 39.91%
$3.64B
$440,000
0.02% of portfolio
7,990
Q2 2023
New
$159B
$628,000
0.02% of portfolio
825
Q1 2024
New
$87.6B
$650,000
0.02% of portfolio
3,050
Q1 2024
Reduced 4.69%
$11.2B
$645,000
0.02% of portfolio
4,900
Q1 2024
Reduced 13.27%
$21.9B
$605,000
0.02% of portfolio
15,667
Q4 2023
Reduced 6.0%
$3.79B
$672,000
0.02% of portfolio
10,860
Q2 2023
Reduced 5.4%
$99.8B
$639,000
0.02% of portfolio
4,300
Q1 2024
Reduced 23.21%
$2.57B
$538,000
0.02% of portfolio
9,000
Q1 2024
Reduced 33.33%
$6.08B
$528,000
0.02% of portfolio
6,300
Q4 2021
Reduced 10.0%
$0
$218,000
0.01% of portfolio
454
Q1 2024
Reduced 33.33%
$191B
$247,000
0.01% of portfolio
3,420
Q1 2024
Reduced 37.76%
$12.9B
$361,000
0.01% of portfolio
9,090
Q1 2024
Reduced 19.49%
$262B
$254,000
0.01% of portfolio
1,409
Q1 2024
Reduced 18.22%
$120B
$240,000
0.01% of portfolio
575
Q4 2023
New
$901B
$231,000
0.01% of portfolio
1,703
Q1 2024
New
$11.2B
$308,000
0.01% of portfolio
16,000
Q3 2020
Reduced 33.33%
$137B
$345,000
0.01% of portfolio
1,357
Q4 2023
Reduced 0.59%
$421B
$269,000
0.01% of portfolio
560
Q1 2024
New
$130B
$414,000
0.01% of portfolio
800
Q3 2020
Reduced 61.9%
$82.7B
$211,000
0.01% of portfolio
140
Q4 2023
New
$40.8B
$299,000
0.01% of portfolio
6,093
Q1 2024
Reduced 37.4%
$11.1B
$272,000
0.01% of portfolio
1,025
Q4 2023
New
$42.7B
$380,000
0.01% of portfolio
3,100
Q1 2024
Reduced 36.73%
$79.5B
$300,000
0.01% of portfolio
2,400
Q1 2024
Reduced 8.68%
$21.3B
$225,000
0.01% of portfolio
5,200
Q4 2023
Reduced 5.45%
$85.8M
$151,000
0.01% of portfolio
32,545
Q4 2022
New
$650B
$397,000
0.01% of portfolio
300
Q3 2023
New
$119B
$212,000
0.01% of portfolio
255
Q4 2023
New
$48.4B
$212,000
0.01% of portfolio
3,696
Q1 2024
New
$30.2B
$265,000
0.01% of portfolio
2,750
Q1 2024
New
$883M
$64,000
0.0% of portfolio
15,000
Q2 2022
Reduced 50.0%
Ge Healthcare Technologies I
-
$0
0.0% of portfolio
-
Q1 2024
Reduced 12.8%
-
$0
0.0% of portfolio
-
Q1 2024
New
$139M
$47,000
0.0% of portfolio
17,500
Q3 2020
New